Guardant’s test analyzes circulating tumor DNA that is then used to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from treatment with the Braftovi combo therapy ...
A new report found that colorectal cancer causes more deaths than any other type of cancer, including breast and lung cancers ...
Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...
INDIANAPOLIS (WISH) – This week, the United States Food and Drug Administration approved Guardant’s Shield blood test to screen for colon cancer in average-risk Americans 45 to 75 years old.
Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...
The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...
The Healthy @Reader's Digest on MSN
Here's how I knew I had colon cancer: One survivor's story after a single, subtle symptom
Colon cancer symptoms often don't exist. An active woman shares how repeated nudges from a loved one led to her diagnosis: "My entire life changed that day." ...
Learn how stool appearance can signal colon cancer. Recognize signs like ribbon-like and pebble-shaped stools, and understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results